Trial Suggestions

Vote on suggested clinical trials and add NCT numbers for the next Endpoint Arena markets.

Trial Suggestions

Submit trial

#1

NCT04850118Sign in to save notifications for this NCT.
A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRPX-Linked Retinitis PigmentosaBeacon TherapeuticsPhase 2 / Phase 3Jun 30, 2026
Status
Active Not Recruiting
Intervention
rAAV2tYF-GRK1-hRPGRco; Control
Primary completion
Jun 30, 2026
Suggestions
1
This week
0
All time
+8
First suggested
Apr 22, 2026
Latest suggestion
Apr 22, 2026
ClinicalTrials.gov

#2

NCT05733546Sign in to save notifications for this NCT.
A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive DisorderMajor Depressive DisorderCOMPASS Pathways (CMPS)Phase 2Sep 2025
Status
Active Not Recruiting
Intervention
Psilocybin
Primary completion
Sep 2025
Suggestions
1
This week
0
All time
+7
First suggested
Apr 13, 2026
Latest suggestion
Apr 13, 2026
ClinicalTrials.gov

#3

NCT06347159Sign in to save notifications for this NCT.
A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)Hypertrophic CardiomyopathyEdgewise Therapeutics, Inc. (EWTX)Phase 2Jun 2026
Status
Active Not Recruiting
Intervention
EDG-7500
Primary completion
Jun 2026
Suggestions
1
This week
0
All time
+2
First suggested
Apr 13, 2026
Latest suggestion
Apr 13, 2026
ClinicalTrials.gov

#4

NCT06109649Sign in to save notifications for this NCT.
A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With VitiligoVitiligoClinuvel, Inc.Phase 3Dec 2025
Status
Active Not Recruiting
Intervention
Afamelanotide and NB-UVB Light; NB-UVB Light
Primary completion
Dec 2025
Suggestions
1
This week
0
All time
0
First suggested
May 23, 2026
Latest suggestion
May 23, 2026
ClinicalTrials.gov

#5

NCT04280705Sign in to save notifications for this NCT.
Adaptive COVID-19 Treatment Trial (ACTT)COVID-19National Institute of Allergy and Infectious Diseases (NIAID)Phase 3May 21, 2020
Status
Completed
Intervention
Placebo; Remdesivir
Primary completion
May 21, 2020
Suggestions
1
This week
0
All time
0
First suggested
Apr 20, 2026
Latest suggestion
Apr 20, 2026
ClinicalTrials.gov

#6

NCT06344104Sign in to save notifications for this NCT.
A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant HypertensionUncontrolled Hypertension; Resistant HypertensionAstraZeneca (AZN)Phase 3Nov 24, 2025
Status
Completed
Intervention
Baxdrostat; Placebo
Primary completion
Nov 24, 2025
Suggestions
1
This week
0
All time
0
First suggested
Apr 14, 2026
Latest suggestion
Apr 14, 2026
ClinicalTrials.gov

#7

NCT06389877Sign in to save notifications for this NCT.
A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)Alpha 1-Antitrypsin DeficiencyBeam Therapeutics Inc. (BEAM)Phase 1 / Phase 2May 2028
Status
Recruiting
Intervention
BEAM-302
Primary completion
May 2028
Suggestions
1
This week
0
All time
0
First suggested
Apr 13, 2026
Latest suggestion
Apr 13, 2026
ClinicalTrials.gov

#8

NCT07420283Sign in to save notifications for this NCT.
A Study of Brenipatide in Participants With Opioid Use DisorderOpioid Use DisorderEli Lilly and Company (LLY)Phase 2Mar 2028
Status
Recruiting
Intervention
Brenipatide; Placebo; Buprenorphine
Primary completion
Mar 2028
Suggestions
1
This week
0
All time
0
First suggested
Apr 12, 2026
Latest suggestion
Apr 12, 2026
ClinicalTrials.gov

#9

NCT07219953Sign in to save notifications for this NCT.
A Study of Brenipatide in Participants With Alcohol Use DisorderAlcohol Use DisorderEli Lilly and Company (LLY)Phase 3Apr 2028
Status
Recruiting
Intervention
LY3537031; Placebo
Primary completion
Apr 2028
Suggestions
1
This week
0
All time
0
First suggested
Apr 12, 2026
Latest suggestion
Apr 12, 2026
ClinicalTrials.gov

#10

NCT06634420Sign in to save notifications for this NCT.
HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)Hereditary AngioedemaIntellia Therapeutics (NTLA)Phase 3Feb 10, 2026
Status
Active Not Recruiting
Intervention
NTLA-2002; Normal Saline IV Administration
Primary completion
Feb 10, 2026
Suggestions
1
This week
0
All time
0
First suggested
Apr 12, 2026
Latest suggestion
Apr 12, 2026
ClinicalTrials.gov

#11

NCT05933577Sign in to save notifications for this NCT.
A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)MelanomaMerck Sharp & Dohme LLC (MRK)Phase 3Oct 26, 2029
Status
Active Not Recruiting
Intervention
Intismeran autogene; Pembrolizumab; Placebo
Primary completion
Oct 26, 2029
Suggestions
1
This week
0
All time
0
First suggested
Apr 12, 2026
Latest suggestion
Apr 12, 2026
ClinicalTrials.gov